ATE310508T1 - Therapeutische formulierung enthaltende dosierungsform - Google Patents

Therapeutische formulierung enthaltende dosierungsform

Info

Publication number
ATE310508T1
ATE310508T1 AT99948122T AT99948122T ATE310508T1 AT E310508 T1 ATE310508 T1 AT E310508T1 AT 99948122 T AT99948122 T AT 99948122T AT 99948122 T AT99948122 T AT 99948122T AT E310508 T1 ATE310508 T1 AT E310508T1
Authority
AT
Austria
Prior art keywords
dosage form
form containing
therapeutic formulation
containing therapeutic
drug formulation
Prior art date
Application number
AT99948122T
Other languages
English (en)
Inventor
Liang C Dong
Patrick S-L Wong
Vincent J Ferrari
Steven D Espinal
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Application granted granted Critical
Publication of ATE310508T1 publication Critical patent/ATE310508T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
AT99948122T 1998-09-08 1999-09-03 Therapeutische formulierung enthaltende dosierungsform ATE310508T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9940198P 1998-09-08 1998-09-08
PCT/US1999/020333 WO2000013674A1 (en) 1998-09-08 1999-09-03 Dosage form comprising therapeutic formulation

Publications (1)

Publication Number Publication Date
ATE310508T1 true ATE310508T1 (de) 2005-12-15

Family

ID=22274837

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99948122T ATE310508T1 (de) 1998-09-08 1999-09-03 Therapeutische formulierung enthaltende dosierungsform

Country Status (10)

Country Link
US (5) US6551613B1 (de)
EP (1) EP1117383B1 (de)
JP (1) JP2002524151A (de)
AT (1) ATE310508T1 (de)
AU (1) AU6136199A (de)
CY (1) CY1105388T1 (de)
DE (1) DE69928554T2 (de)
DK (1) DK1117383T3 (de)
ES (1) ES2249915T3 (de)
WO (1) WO2000013674A1 (de)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6440457B1 (en) * 1993-05-27 2002-08-27 Alza Corporation Method of administering antidepressant dosage form
KR100738276B1 (ko) * 1999-12-09 2007-07-12 알자 코포레이션 항바이러스성 약제
KR20080011353A (ko) 2000-02-24 2008-02-01 몬산토 테크놀로지 엘엘씨 소마토트로핀의 지속적인 방출을 위한 비수성 주사제제들
AU2001271491A1 (en) 2000-06-26 2002-01-08 Monsanto Technology Llc Non-aqueous surfactant-containing formulations for extended release of somatotropin
US6664234B1 (en) 2000-06-30 2003-12-16 Monsanto Technology Llc Non-aqueous injectable formulation preparation with pH adjusted for extended release of somatotropin
CN1606432A (zh) * 2001-12-19 2005-04-13 阿尔扎公司 用于增加亲水性大分子的口服生物利用度的制剂和剂型
USD481456S1 (en) * 2002-01-30 2003-10-28 Smithkline Beecham P.L.C. Capsule
CN1678291A (zh) * 2002-06-28 2005-10-05 阿尔扎公司 含有液态活性药物制剂的口服剂型及其通过可膨胀渗透组合物的控制释放
US20050232995A1 (en) * 2002-07-29 2005-10-20 Yam Nyomi V Methods and dosage forms for controlled delivery of paliperidone and risperidone
EP1556000A1 (de) * 2002-10-31 2005-07-27 Alza Corporation Pharmazeutische formulierung zur erhöhten bioverfügbarkeit hydrophober arzneistoffe
US7731947B2 (en) * 2003-11-17 2010-06-08 Intarcia Therapeutics, Inc. Composition and dosage form comprising an interferon particle formulation and suspending vehicle
CA104544S (en) 2003-04-18 2004-11-01 Ns Planning Inc Capsule
CA104545S (en) 2003-04-18 2004-11-01 Ns Planning Inc Capsule
CA2546549A1 (en) * 2003-07-31 2005-02-10 Alza Corporation Permeation-resistant osmotic engine and dosage form for controlled release of a liquid active agent formulation
DE602004006763T2 (de) * 2003-09-26 2008-02-07 Alza Corp., Mountain View Darreichungsform zur kontrollierten Freisetzung einer Formulierung mit aktivem Mittel und Verfahren zur Herstellung der Darreichungsform
JP2007511519A (ja) * 2003-11-14 2007-05-10 アルザ・コーポレーシヨン 液状投薬形態物におけるトピラメートの制御放出
TWI309984B (en) * 2004-07-30 2009-05-21 Wakunaga Pharma Co Ltd Composition for capsule coating, capsule coating, and capsule agent
ATE413864T1 (de) * 2005-01-27 2008-11-15 Alza Corp Orale osmotische darreichungsform mit membran mit hoher flussdichte
US11246913B2 (en) 2005-02-03 2022-02-15 Intarcia Therapeutics, Inc. Suspension formulation comprising an insulinotropic peptide
WO2006083761A2 (en) 2005-02-03 2006-08-10 Alza Corporation Solvent/polymer solutions as suspension vehicles
CA2605180A1 (en) * 2005-04-19 2006-10-26 Alza Corporation Controlled delivery dosage form of tramadol and gabapentin
USD536700S1 (en) * 2005-04-27 2007-02-13 Steven Landau Cylinder-shaped computer memory device
AR055099A1 (es) * 2005-07-28 2007-08-08 Alza Corp Formulaciones liquidas para la administracion controlada de derivados de bencisoxazol
PL116330U1 (en) * 2005-10-31 2007-04-02 Alza Corp Method for the reduction of alcohol provoked rapid increase in the released dose of the orally administered opioide with prolonged liberation
US20070196487A1 (en) * 2006-02-16 2007-08-23 Geerke Johan H Method and apparatus for drilling orifices in osmotic tablets incorporating near-infrared spectroscopy
KR101106510B1 (ko) 2006-05-30 2012-01-20 인타르시아 세라퓨틱스 인코포레이티드 투피스, 내부채널 삼투압 전달 시스템 유동 조절기
CA2670821C (en) 2006-08-09 2012-05-15 Intarcia Therapeutics, Inc. Osmotic delivery systems and piston assemblies
US7538652B2 (en) * 2006-08-29 2009-05-26 International Business Machines Corporation Electrical component tuned by conductive layer deletion
CA2683610C (en) 2007-04-23 2013-01-08 Intarcia Therapeutics, Inc. Suspension formulations of insulinotropic peptides and uses thereof
US8764702B2 (en) * 2007-07-05 2014-07-01 Baxter International Inc. Dialysis system having dual patient line connection and prime
WO2009102467A2 (en) 2008-02-13 2009-08-20 Intarcia Therapeutics, Inc. Devices, formulations, and methods for delivery of multiple beneficial agents
EP2145643A1 (de) * 2008-07-19 2010-01-20 Markus Storz Portioniertes Arzneimittel
CN102573813B (zh) 2009-08-18 2013-11-06 国立大学法人东北大学 持续药物传递系统
MX378797B (es) 2009-09-28 2025-03-10 Intarcia Therapeutics Inc Establecimiento y/o terminacion rapidos de suministro de estado estable sustancial de farmaco.
EP2516455A4 (de) 2009-12-21 2013-05-22 Ambrx Inc Modifizierte schweine-somatotropin-polypeptide und deren verwendungen
NZ600361A (en) 2009-12-21 2014-06-27 Ambrx Inc Modified bovine somatotropin polypeptides and their uses
US20120208755A1 (en) 2011-02-16 2012-08-16 Intarcia Therapeutics, Inc. Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
CA2853112C (en) 2011-10-25 2018-08-21 Onclave Therapeutics Limited Antibody formulations and methods
US9199044B2 (en) 2012-08-06 2015-12-01 Elwha Llc Devices and methods for wearable injection guides
US10046119B2 (en) 2012-10-30 2018-08-14 Elwha Llc Systems and methods for generating an injection guide
US9629963B2 (en) 2012-10-30 2017-04-25 Elwha Llc Systems and methods for generating an injection guide
US9889085B1 (en) 2014-09-30 2018-02-13 Intarcia Therapeutics, Inc. Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
CN113598842A (zh) 2015-06-03 2021-11-05 因塔西亚制药公司 植入物放置和移除系统
KR102574993B1 (ko) 2016-05-16 2023-09-06 인타르시아 세라퓨틱스 인코포레이티드 글루카곤-수용체 선택적 폴리펩티드 및 이들의 이용 방법
USD860451S1 (en) 2016-06-02 2019-09-17 Intarcia Therapeutics, Inc. Implant removal tool
USD840030S1 (en) 2016-06-02 2019-02-05 Intarcia Therapeutics, Inc. Implant placement guide
WO2018129058A1 (en) 2017-01-03 2018-07-12 Intarcia Therapeutics, Inc. Methods comprising continuous administration of a glp-1 receptor agonist and co-adminstration of a drug
USD933219S1 (en) 2018-07-13 2021-10-12 Intarcia Therapeutics, Inc. Implant removal tool and assembly
CN111251521B (zh) * 2018-12-03 2022-07-22 沈欣 液态珠丸的制造方法

Family Cites Families (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3173876A (en) 1960-05-27 1965-03-16 John C Zobrist Cleaning methods and compositions
NL271831A (de) 1960-11-29
US3276586A (en) 1963-08-30 1966-10-04 Rosaen Filter Co Indicating means for fluid filters
US3546142A (en) 1967-01-19 1970-12-08 Amicon Corp Polyelectrolyte structures
US3541006A (en) 1968-07-03 1970-11-17 Amicon Corp Ultrafiltration process
US3541005A (en) 1969-02-05 1970-11-17 Amicon Corp Continuous ultrafiltration of macromolecular solutions
US3905360A (en) 1971-11-01 1975-09-16 Alza Corp Intrauterine device for governing the reproductive process
US3845770A (en) 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US3916899A (en) 1973-04-25 1975-11-04 Alza Corp Osmotic dispensing device with maximum and minimum sizes for the passageway
US4077407A (en) 1975-11-24 1978-03-07 Alza Corporation Osmotic devices having composite walls
US4111201A (en) 1976-11-22 1978-09-05 Alza Corporation Osmotic system for delivering selected beneficial agents having varying degrees of solubility
US4259323A (en) 1980-03-24 1981-03-31 Hoffmann-La Roche Inc. Potassium chloride emulsion
US4627850A (en) * 1983-11-02 1986-12-09 Alza Corporation Osmotic capsule
JPS60186385A (ja) 1984-01-30 1985-09-21 不二輸送機工業株式会社 ロボツトハンドの微少移動装置
US4772474A (en) * 1985-08-09 1988-09-20 Alza Corporation Dispenser with internal arrangement of lamina means for dispensing beneficial agent
US4729793A (en) * 1985-08-09 1988-03-08 Alza Corporation Composition for manufacturing wall of dispensing device
GB2155889B (en) * 1984-03-21 1988-03-02 Alza Corp Dispenser-capsule
US4743247A (en) * 1984-08-13 1988-05-10 Alza Corporation Process for manufacturing dosage form
US4717718A (en) * 1985-08-09 1988-01-05 Alza Corporation Device for the controlled delivery of a beneficial agent
US4842867A (en) * 1986-05-09 1989-06-27 Alza Corporation Pulsed drug delivery of doxylamine
US5236689A (en) * 1987-06-25 1993-08-17 Alza Corporation Multi-unit delivery system
US5938654A (en) * 1987-06-25 1999-08-17 Alza Corporation Osmotic device for delayed delivery of agent
US5391381A (en) * 1987-06-25 1995-02-21 Alza Corporation Dispenser capable of delivering plurality of drug units
US4853229A (en) * 1987-10-26 1989-08-01 Alza Corporation Method for adminstering tiny pills
US4855141A (en) * 1988-03-25 1989-08-08 Alza Corporation Device comprising means for protecting and dispensing fluid sensitive medicament
US6200600B1 (en) * 1989-02-16 2001-03-13 Btg International Limited Controlled delay release device
US4951494A (en) 1989-10-10 1990-08-28 Alterio Joseph C D Compression rollers with movable shoulder shields
US5213809A (en) * 1990-01-24 1993-05-25 Alza Corporation Delivery system comprising means for controlling internal pressure
US5324280A (en) * 1990-04-02 1994-06-28 Alza Corporation Osmotic dosage system for delivering a formulation comprising liquid carrier and drug
US5443459A (en) * 1991-01-30 1995-08-22 Alza Corporation Osmotic device for delayed delivery of agent
US5223265A (en) * 1992-01-10 1993-06-29 Alza Corporation Osmotic device with delayed activation of drug delivery
US5209746A (en) * 1992-02-18 1993-05-11 Alza Corporation Osmotically driven delivery devices with pulsatile effect
US5869097A (en) * 1992-11-02 1999-02-09 Alza Corporation Method of therapy comprising an osmotic caplet
US5358721A (en) * 1992-12-04 1994-10-25 Alza Corporation Antiviral therapy
PT621032E (pt) * 1993-04-23 2001-01-31 Novartis Ag Dispositivo de distribuicao de libertacao controlada de farmaco
US5446090A (en) * 1993-11-12 1995-08-29 Shearwater Polymers, Inc. Isolatable, water soluble, and hydrolytically stable active sulfones of poly(ethylene glycol) and related polymers for modification of surfaces and molecules
GB9405304D0 (en) * 1994-03-16 1994-04-27 Scherer Ltd R P Delivery systems for hydrophobic drugs
US5633011A (en) 1994-08-04 1997-05-27 Alza Corporation Progesterone replacement therapy
US5614578A (en) 1994-10-28 1997-03-25 Alza Corporation Injection-molded dosage form
AU692255B2 (en) * 1995-04-24 1998-06-04 Yissum Research Development Company Of The Hebrew University Of Jerusalem Self-emulsifiable formulation producing an oil-in-water emulsion
CZ299790B6 (cs) * 1996-08-22 2008-11-26 Skyepharma Canada Inc. Kompozice mikrocástic ve vode nerozpustné látky, farmaceutická kompozice, zpusob prípravy stabilních cástic, mikrocástice ve vode nerozpustné nebo slabe rozpustné slouceniny, kompozice obsahující tyto mikrocástice a zpusob prípravy mikrocástic
FR2765608B1 (fr) * 1997-07-04 1999-09-10 Manuf Stephanoise De Transform Dispositif connecteur d'arceaux de tente
US6087353A (en) * 1998-05-15 2000-07-11 Forbes Medi-Tech Inc. Phytosterol compositions and use thereof in foods, beverages, pharmaceuticals, nutraceuticals and the like
US6445783B1 (en) * 1998-07-14 2002-09-03 At&T Corp. System and method that provides specialized processing of communications based on automatically generated identifiers
US6183466B1 (en) * 1998-08-21 2001-02-06 Alza Corporation Dosage form comprising a capsule
CN101341727B (zh) * 2003-09-26 2012-04-18 迪斯尼企业公司 父母控制的蜂窝电话
US20060293057A1 (en) * 2005-06-24 2006-12-28 Mazerski Thomas M System and method for secure web-based mobile phone parental controls
US20080046930A1 (en) * 2006-08-17 2008-02-21 Bellsouth Intellectual Property Corporation Apparatus, Methods and Computer Program Products for Audience-Adaptive Control of Content Presentation
US7996005B2 (en) * 2007-01-17 2011-08-09 Eagency, Inc. Mobile communication device monitoring systems and methods
EP2044943A1 (de) * 2007-10-04 2009-04-08 Solvay Pharmaceuticals, Inc. Pharmazeutische Zusammensetzungen mit veresterten Östrogenen und Methyltestosteron und Verwendungsverfahren dafür

Also Published As

Publication number Publication date
DK1117383T3 (da) 2006-04-03
WO2000013674A1 (en) 2000-03-16
US20090130204A1 (en) 2009-05-21
US6551613B1 (en) 2003-04-22
CY1105388T1 (el) 2010-04-28
AU6136199A (en) 2000-03-27
DE69928554D1 (de) 2005-12-29
DE69928554T2 (de) 2006-03-30
ES2249915T3 (es) 2006-04-01
US20030157163A1 (en) 2003-08-21
EP1117383A1 (de) 2001-07-25
US20100159002A1 (en) 2010-06-24
JP2002524151A (ja) 2002-08-06
US20080181944A1 (en) 2008-07-31
EP1117383B1 (de) 2005-11-23

Similar Documents

Publication Publication Date Title
DE69928554D1 (de) Therapeutische formulierung enthaltende dosierungsform
PL357144A1 (pl) Nowe postaci dawki podstawionego benzimidazolu oraz sposoby ich zastosowania
IL80149A (en) Pharmaceutical compositions containing toluidide derivatives against graft-versus-host diseases and autoimmune diseases
AU1534699A (en) Osmotic dosage form comprising first and second coats
NO971206D0 (no) Forlenget-frigjöringsformulering
HUP0004383A2 (hu) Hatóanyagként klodronátot és vivőanyagként szilíciumozott mikrokristályos cellulózt tartalmazó gyógyszerészeti készítmény
BR0015188A (pt) Composições farmacêuticas
CY1112260T1 (el) Σκευασματα υδροκωδονης ελεγχομενης απελευθερωσης
ATE424810T1 (de) Ein hydrokolloid und einen celluloseether enthaltende tablette mit verzögerter freisetzung
IS4146A (is) Lyfjablanda til að gefa dýrum um munn sem inniheldur prótonupumpublokkara
DE69620606D1 (de) Feste oral anzuwendende arzeneiform
NZ514129A (en) Tolperison-containing, pharmaceutical preparation for oral administration
EP1365749A4 (de) Prozess zur herstellung von pharmazeutischen zusammensetzungen zur verwendung mit weichgelatine formulierungen
ATE198152T1 (de) Oral anzuwendende arzneizubereitung mit verzögerter wirkstoffabgabe
GEP19991686B (en) Pharmaceutical Composition for Obtaining Effervescent Powder or Tablet, Pharmaceutical Preparation and Method for Preparing Same
DE59907481D1 (de) Kontrolliert freisetzende pharmazeutische zusammensetzung mit tilidinmesylat als wirkstoff
EA199900102A1 (ru) Таблетка малеата тримебутина, покрытая оболочкой
ATE292453T1 (de) Antivirale arznei
HUP9801414A2 (hu) Nátrium-alginátot és kálium-bikarbonátot tartalmazó folyékony vizes gyógyszerkészítmények
GR20010100377A (el) Φαρμακευτικη συνθεση περιεχουσα σιταλοπραμη
SE8901003L (sv) Snabbloesliga preparat
GR890100833A (en) Process for the preparation of a compound with gastric inhibitopy effect
NZ331083A (en) Pharmaceutical preparations of cilansetron stabilized against racemization
BR9912533A (pt) Composição farmacêutica tendo sabor melhorado
NO975634L (no) Stabile farmasöytiske preparater inneholdende tiludronathydrater og fremgangsmåte for fremstilling av farmasöytiske preparater

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1117383

Country of ref document: EP

REN Ceased due to non-payment of the annual fee